Anselamimab
Product Specifications
CAS Number
2414866-63-8
Target
Apolipoprotein, Beta Amyloid
Related Pathways
Metabolism, Neuroscience
Purity
0.98
Bioactivity
Anselamimab is a humanized IgG1κ monoclonal antibody targeting serum amyloid A1 (SAA1) . It removes amyloid deposits by specifically binding to amyloid fibrils and triggering phagocytosis by macrophages and neutrophils.Anselamimab was used as an APP (β-amyloid A4 Protein Precursor) inhibitor in the clinical phase for the treatment of light chain (AL) amyloidosis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
